Data as of Sep 15
| -0.04 / -1.80%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 18.00 and a low estimate of 3.00. The median estimate represents a +198.17% increase from the last price of 2.18.
The current consensus among 4 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.